nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A brief history of the global effort to develop a preventive HIV vaccine
|
Esparza, José |
|
2013 |
31 |
35 |
p. 3502-3518 17 p. |
artikel |
2 |
Afriflu2—Second international workshop on influenza vaccination in the African continent—8 November 2012, Cape Town (South Africa)
|
Schoub, Barry D. |
|
2013 |
31 |
35 |
p. 3461-3466 6 p. |
artikel |
3 |
A systematic review of safety data reporting in clinical trials of vaccines against malaria, tuberculosis, and human immunodeficiency virus
|
Tamminga, Cindy |
|
2013 |
31 |
35 |
p. 3628-3635 8 p. |
artikel |
4 |
Bordetella pertussis iron regulated proteins as potential vaccine components
|
Alvarez Hayes, Jimena |
|
2013 |
31 |
35 |
p. 3543-3548 6 p. |
artikel |
5 |
Characterization of chemically defined poly-N-isopropylacrylamide based copolymeric adjuvants
|
Shakya, Akhilesh Kumar |
|
2013 |
31 |
35 |
p. 3519-3527 9 p. |
artikel |
6 |
Control of humoral immunity and auto-immunity by the CXCR4/CXCL12 axis in lupus patients following influenza vaccine
|
Launay, Odile |
|
2013 |
31 |
35 |
p. 3492-3501 10 p. |
artikel |
7 |
Editorial Board
|
|
|
2013 |
31 |
35 |
p. CO2- 1 p. |
artikel |
8 |
Experimental challenge of chicken vaccinated with commercially available H5 vaccines reveals loss of protection to some highly pathogenic avian influenza H5N1 strains circulating in Hong Kong/China
|
Connie Leung, Y.H. |
|
2013 |
31 |
35 |
p. 3536-3542 7 p. |
artikel |
9 |
Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine compared to a 23-valent pneumococcal polysaccharide vaccine in pneumococcal vaccine-naive adults
|
Jackson, Lisa A. |
|
2013 |
31 |
35 |
p. 3577-3584 8 p. |
artikel |
10 |
Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine in adults 70 years of age and older previously vaccinated with 23-valent pneumococcal polysaccharide vaccine
|
Jackson, Lisa A. |
|
2013 |
31 |
35 |
p. 3585-3593 9 p. |
artikel |
11 |
Immunogenicity and safety of the vaccinia virus LC16m8Δ vector expressing SIV Gag under a strong or moderate promoter in a recombinant BCG prime-recombinant vaccinia virus boost protocol
|
Sato, Hirotaka |
|
2013 |
31 |
35 |
p. 3549-3557 9 p. |
artikel |
12 |
Inactivated Schmallenberg virus prototype vaccines
|
Wernike, Kerstin |
|
2013 |
31 |
35 |
p. 3558-3563 6 p. |
artikel |
13 |
Increased IgG but normal IgA anti-pneumococcal protein antibodies in lung of HIV-infected adults
|
Collins, Andrea M. |
|
2013 |
31 |
35 |
p. 3469-3472 4 p. |
artikel |
14 |
Influence of initial vaccination with 13-valent pneumococcal conjugate vaccine or 23-valent pneumococcal polysaccharide vaccine on anti-pneumococcal responses following subsequent pneumococcal vaccination in adults 50 years and older
|
Jackson, Lisa A. |
|
2013 |
31 |
35 |
p. 3594-3602 9 p. |
artikel |
15 |
In response to: Scientific investigations into febrile reactions observed in the paediatric population following vaccination with a 2010 Southern Hemisphere Trivalent Influenza Vaccine
|
Effler, Paul |
|
2013 |
31 |
35 |
p. 3467-3468 2 p. |
artikel |
16 |
Live attenuated tularemia vaccines: Recent developments and future goals
|
Marohn, Mark E. |
|
2013 |
31 |
35 |
p. 3485-3491 7 p. |
artikel |
17 |
Oligomannose-coated liposome-entrapped dense granule protein 7 induces protective immune response to Neospora caninum in cattle
|
Nishimura, Maki |
|
2013 |
31 |
35 |
p. 3528-3535 8 p. |
artikel |
18 |
Protection against H7N3 high pathogenicity avian influenza in chickens immunized with a recombinant fowlpox and an inactivated avian influenza vaccines
|
Bertran, Kateri |
|
2013 |
31 |
35 |
p. 3572-3576 5 p. |
artikel |
19 |
Protection against pneumococcal infection elicited by immunization with multiple pneumococcal heat shock proteins
|
Cao, Ju |
|
2013 |
31 |
35 |
p. 3564-3571 8 p. |
artikel |
20 |
Protective immunity induced by immunization with a live, cultured Anaplasma marginale strain
|
Hammac, G. Kenitra |
|
2013 |
31 |
35 |
p. 3617-3622 6 p. |
artikel |
21 |
Roadmap for the international collaborative epidemiologic monitoring of safety and effectiveness of new high priority vaccines
|
Izurieta, Hector S. |
|
2013 |
31 |
35 |
p. 3623-3627 5 p. |
artikel |
22 |
Single priming dose of meningococcal group C conjugate vaccine (NeisVac-C®) in infants
|
Poellabauer, Eva-Maria |
|
2013 |
31 |
35 |
p. 3611-3616 6 p. |
artikel |
23 |
Systematic review of economic evaluation analyses of available vaccines in Spain from 1990 to 2012
|
Cortés, Isabel |
|
2013 |
31 |
35 |
p. 3473-3484 12 p. |
artikel |
24 |
Young and elderly patients with type 2 diabetes have optimal B cell responses to the seasonal influenza vaccine
|
Frasca, Daniela |
|
2013 |
31 |
35 |
p. 3603-3610 8 p. |
artikel |